HRT Financial’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,027
Closed -$17K 3590
2024
Q4
$17K Buy
+2,027
New +$19.3K ﹤0.01% 2229
2023
Q3
Sell
-1,808
Closed -$558K 3248
2023
Q2
$558K Buy
1,808
+896
+98% +$275K 0.01% 1304
2023
Q1
$277K Buy
912
+1
+0.1% +$302 ﹤0.01% 1755
2022
Q4
$270K Sell
911
-1
-0.1% -$295 ﹤0.01% 1781
2022
Q3
$266K Hold
912
﹤0.01% 2069
2022
Q2
$264K Hold
912
﹤0.01% 2101
2022
Q1
$266K Buy
912
+116
+15% +$33.6K ﹤0.01% 2316
2021
Q4
$230K Buy
+796
New +$232K ﹤0.01% 2444

Other funds holding XAGE

HRT Financial's XAGE Position: Q1 2025 in Review

HRT Financial sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q1 2025, closing a stake of 2,027 shares — an estimated $17K sold.

HRT Financial first reported a position in XAGE in Q4 2021 and held it in 8 quarters. The position peaked at $558K in Q2 2023. 22 funds tracked by Wall St. Rank hold XAGE as of Q1 2025.

  • HRT Financial reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • HRT Financial sold 2,027 Longevity Health Holdings, Inc. Common Stock shares in Q1 2025, an estimated $17K.
  • HRT Financial first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • HRT Financial's Longevity Health Holdings, Inc. Common Stock position peaked at $558K in Q2 2023.
  • 22 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2025.

Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.